Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report 2023

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report 2023

Table of Contents
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Scope
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018 & 2022 & 2029)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts (2018-2029)
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size in Value Growth Rate (2018-2029)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size in Volume Growth Rate (2018-2029)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends (2018-2029)
2 Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Forecasts by Region
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region: 2018 VS 2022 VS 2029
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2018-2023)
2.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2018-2023)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Region (2024-2029)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
2.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
2.4.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
2.4.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
2.4.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Estimates and Projections (2018-2029)
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Competition Landscape by Players
3.1 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Sales (2018-2023)
3.2 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Players by Revenue (2018-2023)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2022)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Company (2018-2023)
3.5 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Type (2018-2023)
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2018-2023)
4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2018-2023)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2024-2029)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Type (2024-2029)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2024-2029)
5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Review by Application (2018-2023)
5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023)
5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2018-2023)
5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2018-2023)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2024-2029)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Forecast by Application (2024-2029)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2024-2029)
6 United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
6.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
6.1.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
6.1.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
6.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
6.2.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
6.2.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
6.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
6.3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
6.3.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
7 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
7.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
7.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
7.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
7.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
7.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
7.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
8 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
8.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
8.1.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
8.1.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
8.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
8.2.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
8.2.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
8.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
8.3.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
8.3.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
9 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
9.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
9.1.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
9.1.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
9.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
9.2.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
9.2.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
9.3 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
9.3.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
9.3.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
10 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
10.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
10.1.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
10.1.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
10.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
10.2.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
10.3.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
11 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures
11.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company
11.1.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023)
11.1.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023)
11.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type
11.2.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2023)
11.2.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2024-2029)
11.3 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application
11.3.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2023)
11.3.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Glucagon Like Peptide-1 (GLP-1) Agonists Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lily
12.3.1 Eli Lily Corporation Information
12.3.2 Eli Lily Business Overview
12.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.3.5 Eli Lily Recent Development
12.4 GSK
12.4.1 GSK Corporation Information
12.4.2 GSK Business Overview
12.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.4.5 GSK Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.5.5 Sanofi Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Amylin
12.7.1 Amylin Corporation Information
12.7.2 Amylin Business Overview
12.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
12.7.5 Amylin Recent Development
13 Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Analysis
13.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
13.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
14.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
15 Market Dynamics
15.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
15.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
15.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
15.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029)
Table 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Region (2018-2023)
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2018-2023)
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Region (2018-2023)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Region (2024-2029)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Region (2024-2029)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share Forecast by Region (2024-2029)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (K Units) & (2018-2023)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2018-2023)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Company (2018-2023)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2022)
Table 17. Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Sites and Area Served
Table 19. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2018-2023)
Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029)
Table 26. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2024-2029) & (US$ Million)
Table 27. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2024-2029)
Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2024-2029) & (USD/Unit)
Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2018-2023)
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2018-2023) & (USD/Unit)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2024-2029)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2024-2029)
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2024-2029) & (USD/Unit)
Table 38. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 39. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 40. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 42. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 43. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 44. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 45. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 46. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 47. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 48. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 49. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 50. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 51. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 52. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 54. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 55. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 56. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 57. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 58. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 59. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 60. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 61. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 62. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 63. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 64. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 66. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 67. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 68. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 69. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 70. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 71. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 72. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 73. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 74. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 75. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 76. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 78. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 79. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 80. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 81. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 82. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 83. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 84. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 85. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 86. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 87. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 91. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 93. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 94. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 95. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 97. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 98. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2023) & (K Units)
Table 99. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Company (2018-2023)
Table 100. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2018-2023)
Table 102. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023) & (K Units)
Table 103. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 104. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029) & (K Units)
Table 105. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 106. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023) & (K Units)
Table 107. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 108. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029) & (K Units)
Table 109. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 114. Novo Nordisk Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 119. AstraZeneca Recent Development
Table 120. Eli Lily Corporation Information
Table 121. Eli Lily Description and Business Overview
Table 122. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 124. Eli Lily Recent Development
Table 125. GSK Corporation Information
Table 126. GSK Description and Business Overview
Table 127. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 129. GSK Recent Development
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 134. Sanofi Recent Development
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Amylin Corporation Information
Table 141. Amylin Description and Business Overview
Table 142. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 144. Amylin Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 148. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 149. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Table 150. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Table 151. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 152. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) by Type (2018 & 2022 & 2029)
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2022 & 2029
Figure 4. Exenatied Product Picture
Figure 5. Liraglutide Product Picture
Figure 6. Lixisenatide Product Picture
Figure 7. Albiglutide Product Picture
Figure 8. Dulaglutide Product Picture
Figure 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) by Application (2018 & 2022 & 2029)
Figure 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2022 & 2029
Figure 11. Hospital Examples
Figure 12. Pharmacy Examples
Figure 13. Other Examples
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (2018-2029) & (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2018-2029)
Figure 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Trends Growth Rate (2018-2029) & (USD/Unit)
Figure 18. Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million) by Region:2018 VS 2022 VS 2029
Figure 19. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region: 2018 VS 2022
Figure 20. United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 21. United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Growth Rate (2018-2029)
Figure 22. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 23. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate (2018-2029)
Figure 24. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 25. China Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) and Growth Rate (2018-2029)
Figure 26. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 27. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate (2018-2029)
Figure 28. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 29. Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate (2018-2029)
Figure 30. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) Growth Rate (2018-2029)
Figure 31. India Glucagon Like Peptide-1 (GLP-1) Agonists Sales (US$ Million) Growth Rate (2018-2029)
Figure 32. Global 5 Largest Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists: 2018 & 2022
Figure 33. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antidiabetic Thiazolidinediones Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-May-2023        Price: US 3260 Onwards        Pages: 97

The Antidiabetic Thiazolidinediones market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Antidiabetic Thiazolidinediones industry, and breaks down according to the type, application, and consumption area of Antidiabetic Thiazolidinediones. The report also introduces players in the industry from the perspective of the industry ch......

Global Lixisenatide Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 09-May-2023        Price: US 3260 Onwards        Pages: 112

The Lixisenatide market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Lixisenatide industry, and breaks down according to the type, application, and consumption area of Lixisenatide. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading compani......

Global Nateglinide Market Research Report 2023

Published: 04-May-2023        Price: US 2900 Onwards        Pages: 85

Nateglinide is a drug for the treatment of type 2 diabetes, Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs, which should be used to control the high blood sugar of type 2 diabetics by diet and exercise Highlights The global Nateglinide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered ......

Global Insulin Lispro Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 13-Apr-2023        Price: US 3260 Onwards        Pages: 110

The Insulin Lispro market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Insulin Lispro industry, and breaks down according to the type, application, and consumption area of Insulin Lispro. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......

Global Insulin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-Apr-2023        Price: US 3260 Onwards        Pages: 100

Insulin is a peptide hormone produced by beta cells of the pancreatic islets; it is considered to be the main anabolic hormone of the body. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of carbohydrates, especially glucose from the blood into liver, fat and skeletal muscle cells. The Insulin market revenue was 38120.27 Million USD in 2022, and will reach 51020.77 Million USD in 2028, with a CAGR of 4.98% during 2022-2028. This re......

Global Metformin Hydrochloride Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-Apr-2023        Price: US 3260 Onwards        Pages: 120

Metformin Hydrochloride is the hydrochloride salt of the biguanide metformin with antihyperglycemic and potential antineoplastic activities. Metformin hydrochloride improves glucose tolerance by lowering basal and postprandial blood sugar. Metformin hydrochloride can reduce liver glucose production, reduce the intestinal absorption of glucose, and improve insulin sensitivity by increasing the muscle's absorption and utilization of glucose. The Metformin Hydrochloride market revenue was 32......

Global Human Insulin Market Research Report 2023

Published: 07-Apr-2023        Price: US 2900 Onwards        Pages: 90

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans. Highlights The global Human Insulin market was valued at US$ 55850 million in 2022 and is anticipated to reach US$ 105620 million by 2029, witnessing a CAGR of 9.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. In 2018, North America is estimated to domina......

Global Insulin API Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 06-Apr-2023        Price: US 3260 Onwards        Pages: 113

The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Insulin API based on insulin, used to treat diseases such as diabetes. The Insulin API market revenue was 24908.33 Million USD in 2022, and will reach 39473.01 Million USD in 2028, with a CAGR of 7.98% during 2022-2028. This report elaborates the market ......

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 04-Apr-2023        Price: US 3260 Onwards        Pages: 97

Inhibitors of dipeptidyl peptidase 4, also DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2. The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Dipeptidyl ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs